These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30199392)

  • 1. Use of Vasopressor Increases the Risk of Mortality in Traumatic Hemorrhagic Shock: A Nationwide Cohort Study in Japan.
    Aoki M; Abe T; Saitoh D; Hagiwara S; Oshima K
    Crit Care Med; 2018 Dec; 46(12):e1145-e1151. PubMed ID: 30199392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of early administration of vasopressor agents for the resuscitation of severe hemorrhagic shock following blunt trauma.
    Uchida K; Nishimura T; Hagawa N; Kaga S; Noda T; Shinyama N; Yamamoto H; Mizobata Y
    BMC Emerg Med; 2020 Apr; 20(1):26. PubMed ID: 32299385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Field intubation in civilian patients with hemorrhagic shock is associated with higher mortality.
    Chou D; Harada MY; Barmparas G; Ko A; Ley EJ; Margulies DR; Alban RF
    J Trauma Acute Care Surg; 2016 Feb; 80(2):278-82. PubMed ID: 26491803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of the Revised Trauma Score as an entry criterion in traumatic hemorrhagic shock studies: data from the DCLHb clinical trials.
    Sloan EP; Koenigsberg M; Clark JM; Desai A
    Prehosp Disaster Med; 2012 Aug; 27(4):330-44. PubMed ID: 22840198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forgot calcium? Admission ionized-calcium in two civilian randomized controlled trials of prehospital plasma for traumatic hemorrhagic shock.
    Moore HB; Tessmer MT; Moore EE; Sperry JL; Cohen MJ; Chapman MP; Pusateri AE; Guyette FX; Brown JB; Neal MD; Zuckerbraun B; Sauaia A
    J Trauma Acute Care Surg; 2020 May; 88(5):588-596. PubMed ID: 32317575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Early Norepinephrine Administration With 24-Hour Mortality Among Patients With Blunt Trauma and Hemorrhagic Shock.
    Gauss T; Richards JE; Tortù C; Ageron FX; Hamada S; Josse J; Husson F; Harrois A; Scalea TM; Vivant V; Meaudre E; Morrison JJ; Galvagno S; Bouzat P;
    JAMA Netw Open; 2022 Oct; 5(10):e2234258. PubMed ID: 36205999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prehospital end-tidal carbon dioxide predicts hemorrhagic shock upon emergency department arrival.
    Bulger N; Harrington B; Krieger J; Latimer A; Arbabi S; Counts CR; Sayre M; Maynard C; Bulger EM
    J Trauma Acute Care Surg; 2021 Sep; 91(3):457-464. PubMed ID: 34432752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fibrinogen concentrate administration on early mortality in traumatic hemorrhagic shock: A propensity score analysis.
    Hamada SR; Pirracchio R; Beauchesne J; Benlaldj MN; Meaudre E; Leone M; Pottecher J; Abback PS; Gauss T; Boutonnet M; Cook F; Garrigue D; Lesache F; Julie J; Rouquette A; Duranteau J
    J Trauma Acute Care Surg; 2020 May; 88(5):661-670. PubMed ID: 32068718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prehospital fluid resuscitation in hypotensive trauma patients: do we need a tailored approach?
    Geeraedts LM; Pothof LA; Caldwell E; de Lange-de Klerk ES; D'Amours SK
    Injury; 2015 Jan; 46(1):4-9. PubMed ID: 25173671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant humanized monoclonal antibody against CD18 (rhuMAb CD18) in traumatic hemorrhagic shock: results of a phase II clinical trial. Traumatic Shock Group.
    Rhee P; Morris J; Durham R; Hauser C; Cipolle M; Wilson R; Luchette F; McSwain N; Miller R
    J Trauma; 2000 Oct; 49(4):611-9; discussion 619-20. PubMed ID: 11038077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prehospital end-tidal carbon dioxide predicts massive transfusion and death following trauma.
    Campion EM; Cralley A; Robinson C; Sauaia A; Pieracci FM; Lawless RA; Platnick B; Robinson J; Edwards D; McVaney K; Moore EE; Cohen MJ; Coleman JJ; Fox C; Burlew CC
    J Trauma Acute Care Surg; 2020 Oct; 89(4):703-707. PubMed ID: 32590557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The trauma center is too late: Major limb trauma without a pre-hospital tourniquet has increased death from hemorrhagic shock.
    Scerbo MH; Holcomb JB; Taub E; Gates K; Love JD; Wade CE; Cotton BA
    J Trauma Acute Care Surg; 2017 Dec; 83(6):1165-1172. PubMed ID: 29190257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of early use of noradrenaline on in-hospital mortality in haemorrhagic shock after major trauma: a propensity-score analysis.
    Gauss T; Gayat E; Harrois A; Raux M; Follin A; Daban JL; Cook F; Hamada S; ;
    Br J Anaesth; 2018 Jun; 120(6):1237-1244. PubMed ID: 29793591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks and benefits of hypotensive resuscitation in patients with traumatic hemorrhagic shock: a meta-analysis.
    Owattanapanich N; Chittawatanarat K; Benyakorn T; Sirikun J
    Scand J Trauma Resusc Emerg Med; 2018 Dec; 26(1):107. PubMed ID: 30558650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post hoc mortality analysis of the efficacy trial of diaspirin cross-linked hemoglobin in the treatment of severe traumatic hemorrhagic shock.
    Sloan EP; Koenigsberg M; Brunett PH; Bynoe RP; Morris JA; Tinkoff G; Dalsey WC; Ochsner MG;
    J Trauma; 2002 May; 52(5):887-95. PubMed ID: 11988654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated prediction of early blood transfusion and mortality in trauma patients.
    Mackenzie CF; Wang Y; Hu PF; Chen SY; Chen HH; Hagegeorge G; Stansbury LG; Shackelford S;
    J Trauma Acute Care Surg; 2014 Jun; 76(6):1379-85. PubMed ID: 24854304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diaspirin cross-linked hemoglobin infusion did not influence base deficit and lactic acid levels in two clinical trials of traumatic hemorrhagic shock patient resuscitation.
    Sloan EP; Koenigsberg MD; Philbin NB; Gao W; ;
    J Trauma; 2010 May; 68(5):1158-71. PubMed ID: 20145575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in Fluid and Vasopressor Use in Shock With and Without Physiologic Assessment: A Multicenter Observational Study.
    Chen JT; Roberts R; Fazzari MJ; Kashani K; Qadir N; Cairns CB; Mathews K; Park P; Khan A; Gilmore JF; Brown ART; Tsuei B; Handzel M; Lee Chang A; Duggal A; Lanspa M; Herbert JT; Martinez A; Tonna J; Ammar MA; Hammond D; Nazer LH; Heavner M; Pender E; Chambers L; Kenes MT; Kaufman D; Downey A; Brown B; Chaykosky D; Wolff A; Smith M; Nault K; Sevransky J; Gong MN;
    Crit Care Med; 2020 Oct; 48(10):1436-1444. PubMed ID: 32618697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Debunking the survival bias myth: characterization of mortality during the initial 24 hours for patients requiring massive transfusion.
    Brown JB; Cohen MJ; Minei JP; Maier RV; West MA; Billiar TR; Peitzman AB; Moore EE; Cushieri J; Sperry JL;
    J Trauma Acute Care Surg; 2012 Aug; 73(2):358-64; discussion 364. PubMed ID: 22846940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive transfusion practice in non-trauma related hemorrhagic shock.
    Farooq N; Galiatsatos P; Aulakh JK; Higgins C; Martinez A
    J Crit Care; 2018 Feb; 43():65-69. PubMed ID: 28846895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.